VXRT logo
OTC · VXRTBiotechnologyUpdated Nov 4, 2026

Vaxart, Inc. ROE

Profitability, historical returns, and peer comparisons.

The ROE as of November 2026 (TTM) for Vaxart, Inc. (VXRT) is 53.04%

According to Vaxart, Inc.’s latest financial reports and current stock price. The company's current ROE is 53.04%. This represents a change of 891.83% compared to the average of 5.35% of the last 4 quarters.

Vaxart, Inc. (VXRT) Historical ROE (quarterly & annually)

How has VXRT ROE performed in the past?

The mean historical ROE of Vaxart, Inc. over the last ten years is -82.80%. The current 53.04% ROE has changed -164.05% with respect to the historical average. Over the past ten years (40 quarters), VXRT's ROE was at its highest in in the December 2025 quarter at 62.70%. The ROE was at its lowest in in the December 2019 quarter at -49.48%.

Quarterly (TTM)
Annual

Average

-82.80%

Median

-105.52%

Minimum

-160.23%

Maximum

32.18%

Vaxart, Inc. (VXRT) ROE by Quarter and Year

Discovering the peaks and valleys of Vaxart, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 185.97%

Maximum Annual ROE = 32.18%

Minimum Annual Increase = -597.96%

Minimum Annual ROE = -160.23%

Quarterly (TTM)
Annual
YearROEChange
202518.60%-116.37%
2024-113.62%-20.36%
2023-142.66%46.42%
2022-97.43%159.28%
2021-37.58%43.92%
2020-26.11%-81.86%
2019-143.95%-10.16%
2018-160.23%-597.96%
201732.18%-120.47%
2017-157.22%185.97%

Vaxart, Inc. (VXRT) Average ROE

How has VXRT ROE performed in the past?

The current ROE of Vaxart, Inc. (VXRT) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

3-year avg

-79.23%

5-year avg

-74.54%

10-year avg

-82.80%

Vaxart, Inc. (VXRT) ROE vs. Peers

How is VXRT’s ROE compared to its peers?

Vaxart, Inc.’s ROE is less than Novavax, Inc. (159.85%), greater than Vaxcyte, Inc. (-42.04%), greater than Valneva SE (-152.15%), greater than Vir Biotechnology, Inc. (-21.38%), greater than Arcturus Therapeutics Holdings Inc. (-46.54%), greater than GeoVax Labs, Inc. (-743.66%), less than Bavarian Nordic A/S (11.88%), greater than Inovio Pharmaceuticals, Inc. (-1005.80%), greater than Moderna, Inc. (-39.20%), less than Ocugen, Inc. (643.95%),

Build a custom stock screener for Vaxart, Inc. (VXRT) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Vaxart, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Vaxart, Inc. (VXRT) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Vaxart, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the ROE?

How can you use the ROE?

What is Vaxart, Inc.'s ROE?

How is the ROE calculated for Vaxart, Inc. (VXRT)?

What is the highest ROE for Vaxart, Inc. (VXRT)?

What is the 3-year average ROE for Vaxart, Inc. (VXRT)?

What is the 5-year average ROE for Vaxart, Inc. (VXRT)?

How does the current ROE for Vaxart, Inc. (VXRT) compare to its historical average?